financetom
Business
financetom
/
Business
/
Volvo Cars Q1 adjusted operating earnings rise as costs ease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Volvo Cars Q1 adjusted operating earnings rise as costs ease
Apr 23, 2024 10:27 PM

STOCKHOLM (Reuters) -Swedish automaker Volvo Cars reported a rise in first-quarter adjusted operating earnings on Wednesday, helped by lower material costs and higher volumes.

Volvo Cars said its operating income excluding joint ventures, associates and one-offs rose 8% to 6.8 billion Swedish crowns ($629.27 million) in the quarter from a year-ago 6.3 billion.

"We remain firmly focused on achieving profitable growth and we expect 2024 to be another solid year after the record year of 2023," CEO Jim Rowan said in a statement.

($1 = 10.8061 Swedish crowns)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazil's Petrobras to sign deal for four new support vessels built locally
Brazil's Petrobras to sign deal for four new support vessels built locally
Dec 23, 2024
RIO DE JANEIRO (Reuters) - Brazil's Transpetro, a unit of state-run oil firm Petrobras, said on Monday that local shipbuilding firms Ecovix and Mac Laren had won a tender to build four new coastal vessels for $69.5 million per vessel. WHY IT'S IMPORTANT The bid is the first step of Petrobras' plan to renew its fleet of support vessels, and...
Psyence Biomedical Expects to Raise $2 Million From Private Placement
Psyence Biomedical Expects to Raise $2 Million From Private Placement
Dec 23, 2024
08:40 AM EST, 12/23/2024 (MT Newswires) -- Psyence Biomedical ( PBM ) said Monday it has agreed to a private placement of 1 million common shares or pre-funded warrants, along with accompanying series A and series B warrants, priced at $2 each for expected gross proceeds of $2 million. The company said the series A warrants expire in five years,...
Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review
Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review
Dec 23, 2024
08:37 AM EST, 12/23/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) said Monday the US Food and Drug Administration has accepted its new drug application for drug candidate taletrectinib intended for the treatment of non-small cell lung cancer. The FDA granted priority review and set a Prescription Drug User Fee Act goal date of June 23, Nuvation said. Nuvation...
Toyota to build plant to produce EVs in China, Nikkei reports
Toyota to build plant to produce EVs in China, Nikkei reports
Dec 23, 2024
TOKYO, Dec 23 (Reuters) - Toyota Motor ( TM ) has decided to build a new factory to produce electric vehicles in China, the Nikkei business daily reported on Monday. The company will produce its luxury car brand Lexus at a new plant in Shanghai, the Nikkei reported citing several sources. Toyota ( TM ) has worked in China via...
Copyright 2023-2025 - www.financetom.com All Rights Reserved